Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache

Andrew Blumenfeld, David Kudrow, Peter McAllister, Line Pickering Boserup, Joe Hirman, Roger Cady

Open source

DOI
10.1111/head.14767
Published
2024-06-24
Container
Headache: The Journal of Head and Face Pain
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/head.14767,
  title = {Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache},
  author = {Andrew Blumenfeld and David Kudrow and Peter McAllister and Line Pickering Boserup and Joe Hirman and Roger Cady},
  year = {2024},
  journal = {Headache: The Journal of Head and Face Pain},
  doi = {10.1111/head.14767},
  url = {https://doi.org/10.1111/head.14767}
}

RIS

TY  - JOUR
TI  - Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
AU  - Andrew Blumenfeld
AU  - David Kudrow
AU  - Peter McAllister
AU  - Line Pickering Boserup
AU  - Joe Hirman
AU  - Roger Cady
PY  - 2024
JO  - Headache: The Journal of Head and Face Pain
DO  - 10.1111/head.14767
UR  - https://doi.org/10.1111/head.14767
ER  - 

APA

Blumenfeld, A., Kudrow, D., McAllister, P., Boserup, L. P., Hirman, J., & Cady, R. (2024). Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14767

Source records